👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Agilon health director Diana McKenzie buys $44,962 in common stock

Published 12/11/2024, 05:26 PM
AGL
-

Diana McKenzie, a director at agilon health, inc. (NYSE:AGL), recently acquired shares of the company, according to a filing with the Securities and Exchange Commission. The transactions occurred in two separate purchases, coming at a time when the stock has fallen over 80% year-to-date according to InvestingPro data.

On November 25, McKenzie purchased 12,500 shares of agilon health common stock at a price of approximately $2.2779 per share. Subsequently, on December 9, she acquired an additional 7,500 shares at a weighted average price of $2.1985, with prices ranging from $2.1942 to $2.2050. The total value of these purchases amounted to $44,962. These purchase prices are notably close to the stock's current trading level of $2, with InvestingPro analysis indicating the stock is currently undervalued.

Following these transactions, McKenzie now holds 58,819 shares, including restricted stock units. These acquisitions reflect her continued investment in the company as it navigates the healthcare services sector. While the company maintains a strong balance sheet with more cash than debt, InvestingPro analysis reveals several additional key metrics and insights available to subscribers, including detailed financial health scores and comprehensive valuation analysis.

In other recent news, Agilon Health has been experiencing significant changes in its financial performance and market outlook. The company reported a 28% increase in revenue year-over-year, reaching $1.45 billion, but fell short of the projected $1.47 billion. Additionally, Agilon Health experienced an adjusted EBITDA loss of $96 million, significantly missing both the analyst's estimate and the consensus estimate.

Analysts from Bernstein SocGen Group and Jefferies have recently initiated coverage and adjusted the price target for Agilon Health respectively, with both firms awaiting improved performance. TD Cowen and JMP Securities also revised their outlook following the company's financial results, reducing the price target and downgrading the stock rating.

Agilon Health has implemented measures to address its financial challenges, including exiting certain partnerships and renegotiating payer contracts. The company also updated indemnification agreements and relocated its headquarters to Westerville, Ohio. Despite these changes, Agilon Health reported a 37% year-over-year growth in Medicare Advantage membership and raised its full-year membership guidance. These are the latest developments in Agilon Health's operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.